Why Strata Critical Medical, Inc.’s (SRTA) Stock Is Up 7.46%
As of Monday, June 15, Strata Critical Medical, Inc.’s SRTA share price has surged by 7.46%, which has investors questioning if this is right time to sell.Rosalio Madrigal
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Cynthia McLaughlin
Cynthia McLaughlin
Jenna Brashear
Omar Beirat
| Share Statistics | SRTA | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $434.4 | $1,742.7 | 36% |
|
| Shares Out (Mil) | 90.2 | 76.7 | 60% |
|
| Institutional Ownership | 77.2% | 89.7% | 47% |
|
| Float (Mil) | 57.4 | 49.4 | 50% |
|
| Beta | 2.20 | 0.82 | 94% |
|
| Avg Daily Volume (000s) | 1,009 | 521 | 71% |
|
| Price Change (52-week) |
29.4% | 78.7% | 68% |
|
| Growth | SRTA | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 31.3% | 11.0% | 90% |
|
| Net Income (5yr) | 24.8% | (0.7%) | 80% |
|
| EPS (5yr) | 20.5% | 3.1% | 69 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 26.8% | (18.0%) | 84% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | na | 1 | |
| Current EPS | ($0.040) | na | ($0.140) | |
| Month Ago EPS | ($0.040) | na | ($0.140) | |
| # Rev Up | 1 | na | 0 | |
| # Rev Down | 0 | na | 1 | |
| Three Months Ago EPS | ($0.040) | na | ($0.140) | |
| Year/Year Chg | (242.9%) | na | na | |
| Financials | SRTA | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $229 | $1,456 | 33% |
|
| Net Income (TTM) (Mil) | $47 | $12 | 55% |
|
| EPS (TTM) | $0.563 | $0.300 | 55% |
|
| Operating Cash Flow (TTM) (Mil) | ($45) | $138 | 10% |
|
| Net Cash Flow (TTM) (Mil) | na | $8 | na |
|
| Long-Term Debt (Q1) (Mil) | $4 | $316 | 23% |
|
| Enterprise Value (Q1) (Mil) | $416 | $2,170 | 33% |
|
| Valuation | SRTA | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.52 | 2.85 | 40% |
|
| P/E | na | 26.7 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | SRTA | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 21.1% | 27.8% | 22% |
|
| Net Margin | 20.6% | 1.1% | 80% |
|
| ROA | 16.3% | 1.8% | 94% |
|
| ROE | 18.6% | 7.1% | 78% |
|
| Liabilities to Assets | 12.8% | 59.9% | 8% |
|
| F-Score | 2 | 5 | na |
|
Strata Critical Medical, Inc. did not pass any screens on 7/31/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors